Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

TYRA

Tyra Biosciences, Inc. · Healthcare · Biotechnology

26.69 +2.3% mkt cap $1.59B quote delayed (FMP) · as of Aug 25 22:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
10Tracked holders
+1Δ holders
1.73MShares held
$24.09MReported value
+2New positions
−1Exits
Strongly Rising Conviction score 69/100 2 quarters of rising tracked shares ●●○○○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +11.1% · share flow +28.7% · net new positions +10.0%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 70 +2 26.25M $838.89M +9 −7
Q1 2026 71 +10 23.52M $900.04M +12 −2
Q4 2025 61 -1 13.06M $343.28M +1 −2
Q3 2025 17 0 6.63M $92.78M
Q2 2025 14 +2 5.95M $56.99M +2
Q1 2025 9 -1 2.08M $19.36M −1
Q4 2024 10 +1 1.73M $24.09M +2 −1
Q3 2024 8 +5 939.26K $22.08M +5
Q2 2024 3 674.98K $10.79M
Holder count
Who holds it · Q4 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Geode Capital Management (passive) 517.58K -1.1% $7.20M 0.0% ▼ Trim 3 SEC ↗
2 Geode Capital Management (passive) 517.58K -1.1% $7.20M 0.0% ▼ Trim 3 SEC ↗
3 State Street Global Advisors (passive) 407.57K $5.67M 0.0% n/c 1 SEC ↗
4 Millennium Management 315.14K +2900.2% $4.38M 0.0% ▲ Add 2 SEC ↗
5 Adage Capital Partners 200.00K 0.0% $2.78M 0.0% Held 2 SEC ↗
6 Wellington Management 94.86K +4.4% $1.32M 0.0% ▲ Add 3 SEC ↗
7 Wellington Management 94.86K +4.4% $1.32M 0.0% ▲ Add 3 SEC ↗
8 Citadel Advisors 55.59K +132.1% $772,659 0.0% ▲ Add 2 SEC ↗
9 Marshall Wace 54.08K +175.7% $751,671 0.0% ▲ Add 2 SEC ↗
10 Marshall Wace 54.08K +175.7% $751,671 0.0% ▲ Add 2 SEC ↗
11 Two Sigma Investments 46.27K +18.1% $643,139 0.0% ▲ Add 3 SEC ↗
12 Renaissance Technologies 29.10K New $404,490 0.0% New 1 SEC ↗
13 Point72 Asset Management 12.78K New $177,684 0.0% New 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Renaissance Technologies $404,490 0.0%
Point72 Asset Management $177,684 0.0%

Exited

D. E. Shaw & Co. $752,391 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 163 holders, 65.87M shares, $2.48B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q4 2024 · Methodology · Get this via the API